Home
The Department of Biomedicine

News archive for The Department of Biomedicine

Carnosine plays an important roles as antioxidant, pH buffer, and neuromodulator and recently received increasing attention as biomarker for many disease states such as Alzheimer disease and Parkinson disease. The Neurotargeting group at the Department of Biomedicine discovered a novel enzyme, Glutamate Decarboxylase Like 1 (GADL1) that plays a role in carnosine production.
"Immunological, Molecular and Imaging Biomarkers of Malignant Progression in Brain Cancer: Improving Precision Neuro-Oncology"
Charcot-Marie-Tooth disease (CMT) is the most common inherited neuropathy in humans, linked to mutations in dozens of different genes. Two of these genes encode the proteins GDAP1 and NDRG1. We have solved the crystal structures of these two proteins, in order to better understand their structure, function, and involvement in disease.
Researchers at the Department of Biomedicine focus on large RNA structures in bacteria as a target for new antibiotics. Read the latest review article on riboswitches.
The Biorecognition Unit wants to wish everyone a Merry Christmas and a Happy New Year! :-)
The Norwegian Health Association supports the research lab around Helge Wiig who investigates if eating too much salt causes high blood pressure. Read a popular scientific article on forskning.no.
Gro Vatne Røsland is a researcher at the Department of Biomedicine and has written a popular scientific article summarizing current research regarding Vitamin D-intake and infectious diseases.
The SAFETY ZONE is a bright yellow wall featuring equipment you may need in case of an emergency. The wall has raised the level of laboratory safety at the Department and has therefore been awarded this year's work environment award from the Faculty of Medicine.
Ine and Emilie were attending a project course priming them for lab work. They ended up co-developing a method to quality control a cell model which is used by thousands of researchers worldwide.
Professor Rolf Reed from the Department of Biomedicine was awarded the King's Medal of Merit.
Nils Halberg from the Department of Biomedicine will receive almost 8 million kroner from the Norwegian Cancer Society for his research on obesity and pancreatic cancer.
Nils Halberg from the Department of Biomedicine will receive almost 8 million kroner from the Norwegian Cancer Society for his research on obesity and pancreatic cancer.
Best PhD prize 2019 – Andrea Gras Navarro - “Towards Natural Killer cellular Immunotherapy for glioblastoma. KIR-HLA ligand interaction and proteasome inhibitors to potentiate efficacy"
Professor Frits Thorsen and his research group at the ChiNor Research Laboratory has newly received a significant funding of 550 000 RMB over four years (equivalent to 200 000 NOK per year), from the China´s National Natural Science Foundation, for their ongoing research on exosome-derived miRNAs in brain metastases.
Actin is modified by N-terminal acetylation which regulates its role in steering cellular architecture and cell motility. Now the machinery performing this acetylation is uncovered.
Several variants of the NAA10 gene have been found in patients suffering from developmental delay and hemihypertrophy. NAA10 steers the most common protein modification in humans: N-terminal acetylation.
Rolf Bjerkvig of the group for translational cancer research has given a lecture at the Norwegian science festival "Forskningsdagene" in 2020. You can watch a video at the Norwegian Cancer Union.
Few people know the researchers Agnar Nygaard and Kjell Kleppe, but in the 1960s they were part of the world elite that laid the foundation for today's COVID-19 tests. Two permanent exhibitions about the pioneers have now been opened.

Pages